Cross Country Healthcare, Inc. Financial Ratios — CCRN Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	1.65	-18.42	-28.11	-21.88	3.26	5.46	19.32	-7.46	-30.36	-8.18	58.42	49.28	15.71	-3.28	-25.57
Return on Assets (%)	1.18	-12.91	-18.76	-11.09	1.28	2.11	8.76	-3.79	-14.26	-3.51	24.23	22.13	8.92	-2.29	-18.27
Return on Capital (%)	1.8	- -	- -	- -	- -	- -	- -	- -	- -	- -	38.24	35.48	14.4	- -	- -
Return on Invested Capital (%)	0.93	- -	- -	- -	- -	- -	- -	- -	- -	- -	38.07	36.02	16.59	- -	- -
Gross Margin (%)	27.17	25.21	25.89	25.54	25.72	26.6	26.42	25.67	24.81	24.24	22.37	22.28	22.3	20.41	20.26
EBITDA Margin (%)	3.82	0.89	1.68	2.72	4.7	5.03	4.76	3.59	2.68	3.46	9.46	10.71	7.43	3.04	1.22
Operating Margin (%)	1.48	-1.13	0.27	1.51	3.65	3.93	3.58	2.15	0.97	1.94	8.87	10.26	6.52	1.69	-0.37
Incremental Operating Margin (%)	-2.19	- -	-142.53	4.56	12.49	7.12	-5.57	27.64	-166.86	58.32	15.77	12.33	19.9	16.14	- -
Pretax Margin (%)	0.82	-6.08	-2.29	-5.07	0.54	0.55	0.5	-2.23	-2.94	-1.47	7.94	9.03	5.09	-1.22	-7.92
Profit Margin (%)	0.93	-9.54	-11.86	-5.14	0.58	0.96	4.34	-2.08	-7.02	-1.55	7.87	6.63	3.6	-1.08	-9
Net Income to Common Margin (%)	0.93	-9.54	-11.86	-5.14	0.58	0.96	4.34	-2.08	-7.02	-1.55	7.87	6.63	3.6	-1.08	-9
Effective Tax Rate (%)	57.21	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.91	26.52	29.41	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	-0.38	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	1.65	-18.42	-28.11	-21.96	3.26	5.46	19.32	-7.46	-30.36	-8.18	58.42	49.28	15.71	-3.28	-25.57

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	42	34	9	74	89	87	99	83	95	78	195	158	5	4	2
ST Debt	17	34	8	4	8	2	7	5	5	7	8	4	3	2	1
LT Debt	25	- -	- -	70	81	85	92	78	90	71	187	154	3	2	1
Total Debt/EBITDA	2.51	8.58	1.17	4.41	2.48	2.08	2.41	2.84	4.3	2.7	1.23	0.53	0.04	0.09	0.18
Net Debt/EBITDA	1.87	5.93	0.07	4.12	2.41	1.58	1.79	2.29	3.17	1.96	1.13	0.48	-0.11	-2	-8.44
Total Debt/EBIT	6.48	-6.77	7.37	7.93	3.19	2.66	3.2	4.74	11.9	4.8	1.31	0.55	0.04	0.17	-0.59
Net Debt/EBIT	4.84	-4.68	0.45	7.39	3.1	2.03	2.38	3.83	8.77	3.49	1.21	0.5	-0.13	-3.6	27.86
EBITDA to Interest Expense	5.87	1.69	8.65	4.04	5.3	6.86	9.77	5.19	4.16	10.01	23.11	20.86	18.54	18.68	5.82
EBITDA-CapEx/Interest Expense	4.47	0.74	6.59	2.94	4.95	5.8	8.55	4.37	3.6	8.41	22.06	20.25	16.82	14.7	2.13
EBIT to Interest Expense	2.27	-2.14	1.37	2.25	4.12	5.36	7.35	3.1	1.5	5.62	21.67	19.99	16.28	10.36	-1.76
Interest Expense	3	2	1	4	7	6	4	6	5	3	7	14	8	2	2
Common Equity/Total Assets	71.65	68.36	64.72	39.95	38.53	38.94	50.69	50.94	42.53	43.25	40.6	48.24	68.66	71.1	71.91
Long-Term Debt/Equity (%)	10.05	0.08	0.06	54.07	57.52	55.83	38.81	35.72	55.07	45.88	62.92	33.6	0.57	0.43	0.36
Long-Term Debt/Capital (%)	8.6	0.07	0.05	34.47	35.24	35.49	27.39	25.86	34.84	30.51	37.97	24.98	0.56	0.42	0.36
Long-Term Debt/Total Assets (%)	7.2	0.06	0.04	21.67	22.24	21.82	19.73	18.25	23.55	19.91	25.55	16.21	0.39	0.3	0.26
Total Debt/Equity (%)	16.87	16.19	5.34	56.83	63.23	57.31	41.7	38.12	58.06	50.35	65.7	34.5	1.13	0.92	0.72
Total Debt/Capital (%)	14.43	13.93	5.07	36.24	38.74	36.43	29.43	27.6	36.73	33.49	39.65	25.65	1.11	0.92	0.71
Total Debt/Total Assets (%)	12.08	11.07	3.45	22.78	24.45	22.4	21.2	19.48	24.82	21.85	26.68	16.64	0.77	0.66	0.52
Net Debt to Equity	12.59	11.19	0.32	53	61.49	43.72	30.96	30.78	42.78	36.58	60.33	31.74	-3.66	-19.48	-33.68
Net Debt/Capital (%)	11.19	10.06	0.32	34.64	38.08	30.42	23.64	23.54	27.17	24.49	36.49	23.74	-3.75	-23.93	-50.25
EBITDA	17	4	7	17	36	42	41	29	22	29	159	300	150	41	13
EBITDA-CapEx	13	2	6	12	34	35	36	25	19	24	151	291	136	32	5
Operating Income (Loss)	6	-5	1	9	28	33	31	18	8	16	149	288	132	23	-4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.24	0.14	0.18	0.07	0.03	0.21	0.27	0.19	0.01	0.02	0.01	0.01	0.11	0.68	1.4
Current Ratio	2.14	1.91	1.87	1.96	1.84	2.12	2.21	2.28	2.15	1.96	2.54	2.49	2.67	2.78	3.78
Quick Ratio	1.78	1.09	1.71	1.85	1.77	2.03	2.14	2.18	2.05	1.89	2.5	2.44	2.61	2.7	3.66
CFO/Avg Current Liab	0.42	0.16	0.15	-0.07	0.24	0.33	0.47	0.23	0.06	0.3	-0.58	0.57	1.16	0.87	0.49
Common Equity/Total Assets	71.65	68.36	64.72	39.95	38.53	38.94	50.69	50.94	42.53	43.25	40.6	48.24	68.66	71.1	71.91
Long-Term Debt/Equity (%)	10.05	0.08	0.06	54.07	57.52	55.83	38.81	35.72	55.07	45.88	62.92	33.6	0.57	0.43	0.36
Long-Term Debt/Capital (%)	8.6	0.07	0.05	34.47	35.24	35.49	27.39	25.86	34.84	30.51	37.97	24.98	0.56	0.42	0.36
Long-Term Debt/Total Assets (%)	7.2	0.06	0.04	21.67	22.24	21.82	19.73	18.25	23.55	19.91	25.55	16.21	0.39	0.3	0.26
Total Debt/Equity (%)	16.87	16.19	5.34	56.83	63.23	57.31	41.7	38.12	58.06	50.35	65.7	34.5	1.13	0.92	0.72
Total Debt/Capital (%)	14.43	13.93	5.07	36.24	38.74	36.43	29.43	27.6	36.73	33.49	39.65	25.65	1.11	0.92	0.71
Total Debt/Total Assets (%)	12.08	11.07	3.45	22.78	24.45	22.4	21.2	19.48	24.82	21.85	26.68	16.64	0.77	0.66	0.52
CFO/Total Liabilities	18.55	10.48	9.89	-2.09	8.13	12.74	19.79	10.06	2.53	13.46	-19.67	27.32	116.44	70.54	38.26
CFO/CapEx	4.58	4.57	4.95	-0.89	7.72	4.62	8.9	4.57	1.89	5.89	-11.94	15.26	17.78	13.78	5.91
Altman's Z-Score	5.18	3.47	5.74	4.67	5.61	5.2	5.04	4.3	4.47	4.42	5.85	7.22	8.49	6.87	5.34

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	6.45	6.58	7.1	7.11	5.9	5.2	4.98	4.81	4.9	4.93	5.05	4.94	3.98	4.51	5.4
Days Sales Outstanding	56.57	55.45	51.39	51.36	61.83	70.17	73.25	75.94	74.5	74.08	72.27	73.92	91.62	80.87	67.64
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	70.97	34.58	31.85	24.48	16.67	12.24	11.63	12.87	13.82	13.26	16.31	35.54	197.36	243.57	215.9
Accounts Payable Turnover Days	5.14	10.56	11.46	14.91	21.9	29.81	31.38	28.37	26.41	27.53	22.38	10.27	1.85	1.5	1.69
Cash Conversion Cycle	51.43	44.89	39.93	36.45	39.93	40.36	41.87	47.57	48.09	46.55	49.88	63.65	89.77	79.38	65.95
Inventory to Cash Days	56.57	55.45	51.39	51.36	61.83	70.17	73.25	75.94	74.5	74.08	72.27	73.92	91.62	80.87	67.64
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	171	148	310	391	524	505	457	261	417	321	1,028	965	778	586	257
- Cash & Cash Equivalents	11	10	8	5	2	21	26	16	1	2	1	4	17	82	109
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	1	1	1	1	1	- -	- -	- -	- -	- -
+ Total Debt	42	34	9	74	89	87	99	83	95	78	195	158	5	4	2
Enterprise Value	201	172	311	460	611	572	532	329	512	398	1,222	1,119	767	508	151
Total Capital	291	243	169	204	231	239	337	301	258	233	493	615	473	423	325
Total Debt/Capital (%)	14.43	13.93	5.07	36.24	38.74	36.43	29.43	27.6	36.73	33.49	39.65	25.65	1.11	0.92	0.71
Total Debt / EV	0.21	0.2	0.03	0.16	0.15	0.15	0.19	0.25	0.19	0.2	0.16	0.14	0.01	0.01	0.02
EV/Sales	0.46	0.39	0.71	0.74	0.8	0.69	0.61	0.4	0.62	0.48	0.73	0.4	0.38	0.38	0.14
EV/EBITDA	11.97	43.5	42.32	27.41	16.93	13.64	12.92	11.21	23.2	13.75	7.7	3.73	5.11	12.44	11.68
EV/EBIT	30.95	- -	267.2	49.23	21.81	17.47	17.16	18.74	64.15	24.48	8.21	3.89	5.82	22.42	- -
EV/Cash Flow to Firm	10.28	14.37	23.46	3,942.57	23.2	13.65	6.36	12.71	28.74	13.24	- -	7.74	3.02	4.17	2.96
EV/Free Cash Flow to Firm	8.54	12.12	20.72	98.14	21.29	11.81	6	10.79	24.66	11.48	- -	7.29	2.86	3.89	2.55
Diluted Market Cap	173	148	309	389	527	566	461	261	416	320	1,038	997	803	606	263
Diluted Enterprise Value	205	171	310	459	615	633	536	329	511	397	1,232	1,151	791	528	156
EV per Share	6.51	5.56	10	14.7	19.13	17.68	14.83	9.23	14.26	11	33.01	30.82	22.3	15.75	4.75
TTM Sales	439	443	438	618	767	834	865	816	822	836	1,677	2,803	2,020	1,344	1,054
TTM EBITDA	17	4	7	17	36	42	41	29	22	29	159	300	150	41	13
TTM Operating Income	6	-5	1	9	28	33	31	18	8	16	149	288	132	23	-4
TTM Cash Flow to Firm	20	12	13	- -	26	42	84	26	18	30	-79	145	254	122	51
TTM Free Cash Flow to Firm	24	14	15	5	29	48	89	30	21	35	-72	153	268	131	59

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	7.77	11.97	29.73	780.06	25.59	15.43	9.12	10.21	49.07	10.06	-13.23	6.98	3.06	4.71	4.65
EV/EBIT	30.95	- -	267.2	49.23	21.81	17.47	17.16	18.74	64.15	24.48	8.21	3.89	5.82	22.42	- -
Enterprise Value	201	172	311	460	611	572	532	329	512	398	1,222	1,119	767	508	151
Low Price	3.76	3.8	4.59	5.26	9.36	9.72	11.07	6.91	6.75	4.5	8.6	15.26	15.65	9.58	7.43
EV/Sales	0.46	0.39	0.71	0.74	0.8	0.69	0.61	0.4	0.62	0.48	0.73	0.4	0.38	0.38	0.14
EV/EBITDA	11.97	43.5	42.32	27.41	16.93	13.64	12.92	11.21	23.2	13.75	7.7	3.73	5.11	12.44	11.68
Price/Earnings	42.18	- -	- -	- -	116.91	62.96	11.91	- -	- -	- -	7.72	5.29	10.96	- -	- -
Price/Earnings Average	48.44	-3.46	-3.48	-8.42	93.41	53.28	12.44	-22.62	-5.81	-20.91	4.81	4.92	11.84	-36.6	-4.68
Price/Earnings High	70.38	-4.92	-6.28	-13.26	133.82	65.54	15.29	-30.1	-8.06	-37.36	8.45	7.98	15.4	-54.21	-6.25
Price/Earnings Low	28.58	-2.78	-2.74	-5.16	66.77	39.2	10.33	-14.54	-4.19	-12.53	2.39	3.04	7.58	-21.97	-2.54
Price/Book Value	0.69	0.71	1.93	3.01	3.72	3.34	1.93	1.2	2.56	2.08	3.45	2.11	1.66	1.4	0.8
Price/Book Value Average	0.79	0.7	1.13	2.07	2.97	2.82	2.01	1.76	2.07	1.76	2.15	1.96	1.8	1.23	1.35
Price/Book Value High	1.14	0.99	2.04	3.26	4.26	3.47	2.48	2.34	2.87	3.14	3.78	3.19	2.34	1.82	1.8
Price/Book Value Low	0.46	0.56	0.89	1.27	2.12	2.08	1.67	1.13	1.49	1.05	1.07	1.21	1.15	0.74	0.73
Price/Tangible Book Value	5.23	1.78	20.82	-11.91	-14.09	-786.32	14.37	6.39	38.92	14.12	7.92	3.87	2.8	2.43	1.11
Price/Tangible Book Value Average	6	1.76	12.17	-8.18	-11.26	-665.39	15.01	9.37	31.36	11.96	4.94	3.6	3.03	2.13	1.88
Price/Tangible Book Value High	8.72	2.5	21.97	-12.89	-16.13	-818.56	18.45	12.47	43.51	21.37	8.67	5.84	3.94	3.16	2.51
Price/Tangible Book Value Low	3.54	1.41	9.57	-5.02	-8.05	-489.62	12.47	6.02	22.61	7.17	2.45	2.22	1.94	1.28	1.02
Price/Sales	0.39	0.33	0.71	0.63	0.67	0.6	0.52	0.32	0.51	0.38	0.61	0.35	0.39	0.45	0.25
Price/Sales Average	0.45	0.33	0.41	0.43	0.54	0.51	0.54	0.47	0.41	0.32	0.38	0.33	0.43	0.4	0.42
Price/Sales High	0.66	0.47	0.74	0.68	0.77	0.63	0.66	0.62	0.57	0.58	0.67	0.53	0.55	0.59	0.56
Price/Sales Low	0.27	0.26	0.32	0.27	0.38	0.37	0.45	0.3	0.29	0.19	0.19	0.2	0.27	0.24	0.23
Price/Cash Flow	9.45	14.59	35.74	-95.59	28.33	16.64	9.82	12.45	75.09	11.77	-11.9	7.34	3.2	5.05	5.44
Price/Cash Flow Average	10.85	14.39	20.9	-65.69	22.63	14.08	10.26	18.26	60.51	9.96	-7.42	6.83	3.46	4.44	9.21
Price/Cash Flow High	15.76	20.46	37.71	-103.48	32.42	17.32	12.6	24.3	83.95	17.8	-13.03	11.08	4.5	6.57	12.29
Price/Cash Flow Low	6.4	11.55	16.44	-40.29	16.18	10.36	8.52	11.73	43.62	5.97	-3.69	4.21	2.21	2.66	4.99
Price/Free Cash Flow Average	8.92	11.8	17.38	536.05	20.45	13.06	9.52	14.98	39.54	8.52	-8.25	6.5	3.31	4.14	7.88
Price/Free Cash Flow High	12.96	16.79	31.37	844.44	29.29	16.06	11.7	19.94	54.85	15.22	-14.49	10.54	4.3	6.12	10.51
Price/Free Cash Flow Low	5.26	9.48	13.67	328.78	14.62	9.61	7.91	9.63	28.5	5.1	-4.1	4.01	2.12	2.48	4.27
EV/Sales Average	0.52	0.38	0.42	0.55	0.66	0.59	0.64	0.55	0.52	0.42	0.5	0.38	0.41	0.33	0.31
EV/Sales High	0.72	0.52	0.75	0.8	0.89	0.71	0.76	0.71	0.68	0.67	0.79	0.57	0.54	0.51	0.45
EV/Sales Low	0.34	0.32	0.33	0.38	0.5	0.46	0.54	0.38	0.41	0.29	0.31	0.25	0.26	0.17	0.12
EV/EBITDA Average	13.58	42.97	24.77	20.13	14.02	11.79	13.41	15.37	19.53	12.05	5.26	3.5	5.53	10.7	25.48
EV/EBITDA High	18.89	58.6	44.65	29.33	19.03	14.13	16.07	19.69	25.43	19.45	8.32	5.36	7.21	16.77	36.78
EV/EBITDA Low	8.78	35.67	19.5	13.95	10.71	9.1	11.44	10.7	15.28	8.29	3.23	2.36	3.51	5.66	10.03
EV/EBIT Average	35.12	-33.93	156.42	36.16	18.05	15.1	17.82	25.69	54	21.45	5.61	3.66	6.29	19.29	-84.16
EV/EBIT High	48.83	-46.27	281.9	52.68	24.51	18.1	21.35	32.91	70.31	34.61	8.87	5.6	8.22	30.22	-121.47
EV/EBIT Low	22.7	-28.16	123.13	25.05	13.79	11.65	15.2	17.89	42.24	14.75	3.45	2.46	4	10.21	-33.12
Last Price	5.55	4.8	9.98	12.48	16.39	15.61	12.76	7.33	11.62	8.87	27.76	26.57	22.64	18.16	8.1
High Price	9.26	6.73	10.53	13.51	18.76	16.25	16.38	14.31	12.99	13.42	30.4	40.12	31.82	23.64	18.3
Enterprise Value Average	228	170	182	338	506	494	552	451	431	349	835	1,052	829	437	328
Enterprise Value High	317	231	328	492	687	592	661	578	561	562	1,320	1,611	1,082	685	474
Enterprise Value Low	147	141	143	234	386	381	471	314	337	240	513	708	526	231	129

Shares Outstanding	31	31	31	31	32	32	36	36	36	36	37	36	34	32	32
Diluted Weighted Avg Shares	31	31	31	31	32	36	36	36	36	36	37	38	35	33	32
Basic Weighted Avg Shares	31	31	31	31	32	32	35	36	36	36	37	37	35	33	32
Revenue per Share	14.11	14.35	14.13	19.81	24.35	25.94	24.7	22.9	22.96	23.18	45.7	75.74	57.45	40.26	32.53
EBITDA per Share	0.54	0.13	0.24	0.54	1.15	1.3	1.18	0.82	0.62	0.8	4.32	8.11	4.27	1.22	0.4
Operating Income per Share	0.21	-0.16	0.04	0.3	0.89	1.02	0.88	0.49	0.22	0.45	4.06	7.77	3.75	0.68	-0.12
Basic EPS, GAAP	0.13	-1.37	-1.68	-1.02	0.14	0.25	1.07	-0.48	-1.61	-0.36	3.6	5.02	2.07	-0.44	-2.93
Basic EPS from Cont Ops	0.05	-0.67	-1.75	-1.01	0.16	0.27	1.11	-0.44	-1.56	-0.34	3.6	5.02	2.07	-0.44	-2.93
Diluted EPS, GAAP	0.13	-1.37	-1.68	-1.02	0.14	0.22	1.04	-0.48	-1.61	-0.36	3.53	4.95	2.05	-0.44	-2.93
Diluted EPS from Cont Ops	0.05	-0.67	-1.75	-1.01	0.15	0.24	1.07	-0.44	-1.56	-0.34	3.53	4.95	2.05	-0.44	-2.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.59	0.33	0.28	-0.13	0.58	0.94	1.3	0.59	0.15	0.75	-2.33	3.62	7.07	3.6	1.49
Free Cash Flow per Basic Share	0.46	0.26	0.22	-0.28	0.5	0.74	1.15	0.46	0.07	0.63	-2.53	3.38	6.67	3.34	1.24
Cash & Equivalents per Share	0.4	0.34	0.26	0.16	0.08	0.64	0.71	0.45	0.03	0.04	0.03	0.1	0.5	2.53	3.43
Book Value per Share	8.09	6.77	5.17	4.15	4.41	4.68	6.62	6.11	4.53	4.27	8.04	12.59	13.6	12.98	10.18
Tangible Book Value per Share	1.06	2.69	0.48	-1.05	-1.16	-0.02	0.89	1.15	0.3	0.63	3.51	6.87	8.08	7.49	7.29

Cross Country Healthcare, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)